Nasal spray that kills migraines instantly will hit the market

In the United States, last Friday (10), the Food and Drug Administration approved Pfizer's nasal spray for the treatment of migraine. The medication, according to the project of one of the largest pharmaceutical industries, may be launched on the market as Zavzpret, with the possible date set for July this year.

In the United States, about 39 million people face the condition of having frequent migraines and it is among the six diseases that most affect people worldwide. In Brazil, according to the WHO (World Health Organization), about 31 million Brazilians suffer from migraine.

Angela Hwang, chief commercial officer at Pfizer, says FDA approval for the market means a big breakthrough for the treatment of people who suffer from migraine and do not have immediate options for the treatment. In most cases, people opt for oral medications and long-term treatments.

Nasal spray for migraine treatment

The nasal spray guaranteed an immediate effect in the third phase of testing. Volunteers who were suffering from a migraine attack reported relief within 15 minutes. The product ensures that the body immediately receives the Zavzpret treatment and will also be an alternative option for those who cannot ingest strong medications that cause nausea.

In studies, palliative medication considers a significant reduction in pain two hours after application. In addition to the severe headache that migraines can cause, sensitivity to light and frequent nausea also accompany the person during a crisis. The spray has been shown to be effective for all symptoms.

Pfizer's investment was US$ 10 billion when acquiring Zavzpret and others medicines against migraine from Biohaven. The launch has not yet been announced by the company, but it is expected that they announce the date before the month of July.

Lover of movies and series and everything that involves cinema. An active curious on the networks, always connected to information about the web.